Receptos Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
68
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$7.63B
Receptos General Information
Description
Operator of a biopharmaceutical company intended to discover, develop and commercialize innovative therapeutics for immune and autoimmune diseases. The company offers G protein-coupled receptor structure-based drug design technology and oral small-molecule therapeutic candidates, enabling healthcare providers and patients to access differentiated treatments for relapsing multiple sclerosis, inflammatory bowel disease and other immune-mediated conditions with improved safety and clinical efficacy.
Contact Information
Website
www.receptos.comCorporate Office
- 3033 Science Park Road
- Suite 300
- San Diego, CA 92121
- United States
Corporate Office
- 3033 Science Park Road
- Suite 300
- San Diego, CA 92121
- United States
Receptos Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 27-Aug-2015 | $7.63B | Completed | Generating Revenue | ||
| 6. Merger/Acquisition | 11-Jun-2015 | Cancelled | Generating Revenue | |||
| 5. Secondary Transaction - Open Market | 02-Apr-2015 | Completed | Generating Revenue | |||
| 4. Secondary Transaction - Open Market | 07-Apr-2014 | Completed | Generating Revenue | |||
| 3. IPO | 09-May-2013 | Completed | Clinical Trials - Phase 2 | |||
| 2. Later Stage VC (Series B) | 27-Mar-2013 | $60M | $87.6M | Completed | Generating Revenue | |
| 1. Early Stage VC (Series A) | 23-Nov-2009 | $27.6M | $27.6M | Completed | Product Development |
Receptos Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Receptos Comparisons
Industry
Financing
Details
Receptos Competitors (77)
One of Receptos’s 77 competitors is PEP-Therapy, a Venture Capital-Backed company based in Evry Cedex, France.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| PEP-Therapy | Venture Capital-Backed | Evry Cedex, France | ||||
| Enterome | Venture Capital-Backed | Paris, France | ||||
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Adimab | Venture Capital-Backed | Lebanon, NH | ||||
| Sorrento Therapeutics | Formerly VC-backed | San Diego, CA |
Receptos Signals
Receptos Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| ARCH Venture Partners | Venture Capital | Minority | ||
| Advanced Technology Ventures | Venture Capital | Minority | ||
| Altitude Life Science Ventures | Venture Capital | Minority | ||
| Flagship Pioneering | Venture Capital | Minority | ||
| Lilly Ventures | Corporate Venture Capital | Minority |
Receptos FAQs
-
When was Receptos founded?
Receptos was founded in 2007.
-
Where is Receptos headquartered?
Receptos is headquartered in San Diego, CA.
-
What is the size of Receptos?
Receptos has 68 total employees.
-
What industry is Receptos in?
Receptos’s primary industry is Drug Discovery.
-
Is Receptos a private or public company?
Receptos is a Private company.
-
What is the current valuation of Receptos?
The current valuation of Receptos is .
-
What is Receptos’s current revenue?
The current revenue for Receptos is .
-
How much funding has Receptos raised over time?
Receptos has raised $156M.
-
Who are Receptos’s investors?
ARCH Venture Partners, Advanced Technology Ventures, Altitude Life Science Ventures, Flagship Pioneering, and Lilly Ventures are 5 of 11 investors who have invested in Receptos.
-
Who are Receptos’s competitors?
PEP-Therapy, Enterome, Centrexion Therapeutics, Adimab, and Sorrento Therapeutics are some of the 77 competitors of Receptos.
-
When was Receptos acquired?
Receptos was acquired on 27-Aug-2015.
-
Who acquired Receptos?
Receptos was acquired by Celgene.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process